drugset / Trial / NCT03523832

Preemptive Analgesia in Total Knee Arthroplasty

NCT03523832

Phase 2 Completed 30 enrolled Faculty of Medicine, University of Indonesia
RandomizedFactorialTriple-blindTreatment

Summary

Acute Pain is the most common early complication after total knee arthroplasty that caused delayed mobilization, demands of morphine, and higher operative cost. There were many researches that had been done in analgesia method to find the most effective analgesia, lowest side effect, and easy to apply. Preemptive analgesia of combined celecoxib and pregabalin were reported to give a promising outcome. In a randomized, double blind controlled clinical trial, 30 subjects underwent surgery for total knee arthroplasty using 15-20mg bupivacaine 5% epidural anesthesia. All subjects were divided into three groups. First group was given celecoxib 400mg and pregabaline 150mg 1 hour before operation, second group was given celecoxib 200mg and pregabaline 75mg twice daily started from 3 days before operation, and the last group was given placebo. The outcome was measured with VAS, knee ROM, and post-operative mobilization

Timeline

Start
2015-07-01
Primary completion
2016-12-01
Completion
2016-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 200 mg
Comparator Celecoxib Other / unclassified 400 mg
Comparator Pregabalin Small molecule 75 mg
Comparator Pregabalin Small molecule 150 mg

Indications

No indication recorded.